Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dexcom (DXCM) Net Income (2016 - 2025)

Historic Net Income for Dexcom (DXCM) over the last 17 years, with Q4 2025 value amounting to $267.3 million.

  • Dexcom's Net Income rose 7620.3% to $267.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $836.3 million, marking a year-over-year increase of 4514.06%. This contributed to the annual value of $836.3 million for FY2025, which is 4514.06% up from last year.
  • According to the latest figures from Q4 2025, Dexcom's Net Income is $267.3 million, which was up 7620.3% from $283.8 million recorded in Q3 2025.
  • In the past 5 years, Dexcom's Net Income ranged from a high of $283.8 million in Q3 2025 and a low of -$5.3 million during Q4 2021
  • In the last 5 years, Dexcom's Net Income had a median value of $110.6 million in 2023 and averaged $125.6 million.
  • Per our database at Business Quant, Dexcom's Net Income crashed by 10128.86% in 2021 and then soared by 183207.55% in 2022.
  • Quarter analysis of 5 years shows Dexcom's Net Income stood at -$5.3 million in 2021, then skyrocketed by 1832.08% to $91.8 million in 2022, then skyrocketed by 179.19% to $256.3 million in 2023, then tumbled by 40.81% to $151.7 million in 2024, then soared by 76.2% to $267.3 million in 2025.
  • Its Net Income stands at $267.3 million for Q4 2025, versus $283.8 million for Q3 2025 and $179.8 million for Q2 2025.